Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The first public hearings into New Zealand's Covid-19 response continue on Thursday, with vaccine safety to be discussed. Northland's business community has told a Royal Commission of Inquiry that ...

A Pennsylvania Representative is looking to ban testing mRNA vaccines on domestic animals. Representative Jacob Banta (R-Erie) argued in his newest bill that there are ...

A lack of clear communication from the government may have contributed to the spread of Covid-19 misinformation in the Māori ...

Karen Conti, Chicago trial attorney, joins Bob Sirott to talk about why multiple medical groups brought a lawsuit against ...